- Why Research
- Our Impact
- Get Involved
- About BCRF
- Research is the reason
- Contact Us
You are here
A BCRF researcher for two decades, Dr. Wigler shares his pioneering work in molecular biology.
BCRF investigator Kent Osborne discusses the successes, challenges and opportunities in treatment for HER2-positive breast cancer.
BCRF researcher Dr. Charles Perou has helped categorize TNBC tumors into 4 distinct molecular subtypes.
BCRF investigators Fabrice André, Sarat Chandalapaty, and Nikhil Wagle address the challenges of resistance to CDK4/6 inhibitors.
The Breast Cancer Awareness Commemorative Coin Program became available for sale on March 15 at noon.
BCRF salutes the achievements of its female investigators.
The coin program will include the first-ever gold coin in a pink hue.